AI Could Improve Heart Attack Diagnosis in Emergency Departments
Researchers found that CoDE-ACS was able to rule out a heart attack in more than double the number of patients, with an accuracy of 99.6%.
Researchers found that CoDE-ACS was able to rule out a heart attack in more than double the number of patients, with an accuracy of 99.6%.
Researchers devised a new biomarker-based strategy to screen for a deadly complication caused by monoclonal antibodies used to treat cancer.
A new study found that levels an immune protein known to play a role in kidney disease are high in patients with heart failure.
The test can screen gene mutations to pinpoint the exact mutations harmful to those suffering inherited heart disorder syndromes.
Read MoreDigital health provider Caretaker Medical has received FDA 510(k) clearance for four new continuous hemodynamic parameters.
Read MoreWhen exactly patients should undergo genetic assessment for a heart condition was recently detailed in an international consensus document.
Read MoreMeasurement of dozens of types of fats in the blood can predict the risk of developing type 2 diabetes and cardiovascular disease years before their onset.
Read MoreDiagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic tools when applied to postoperative patients.
Read MoreResearchers have discovered that genomic screening can help identify patients who are at risk for heart disease associated with amyloidosis.
Read MoreResearchers are developing a deep learning network capable of detecting disease biomarkers with a much higher degree of accuracy.
Read MoreA study finds high levels of a specific protein circulating in the blood can accurately detect severe peripheral artery disease risk.
Read MoreA genomics initiative called In Our DNA SC has been launched to improve health care outcomes by integrating genetic insights.
Read MoreNatera, Inc. has announced the validation and availability of its Prospera Heart transplant assessment test for heart transplant recipients.
Read MoreRisk for heart disease does not look the same on the genetic level for different population groups, according to researchers.
Read MoreCardiovascular genetic testing in children presents unique challenges, requiring pre- and post-test counseling with an individualized approach for families.
Read MoreResearchers conducted study to determine if providing genetic testing for patients in cardiovascular clinics would benefit clinical care.
Read MoreA new study identifies DNA signatures associated with risk for cardiovascular disease, which could lead to treatment years before symptoms.
Read MoreBeckman Coulter has definitive agreements to obtain all rights to the manufacture, distribution, and sale of a BNP assay for its analyzers.
Read More